Content about European Union

May 7, 2013
U.S. to contribute to 'rapid' biosimilar market growth through 2023, study finds

The global market for biosimilars will be worth nearly $2.5 billion this year, according to a new study.

May 2, 2013
Beiersdorf off to 'good start' for 2013

Skin care brand Beiersdorf announced on Thursday that it has “continued last year’s positive trend in the first quarter of 2013.”

January 30, 2013
Campaigners celebrate as EU set to ban animal testing for cosmetics

A ban on importing and selling animal-tested cosmetics products and ingredients will enter into force in March. The ban affects all cosmetics, including toiletries and beauty products.

November 12, 2012
Reports: P&G, Teva partner on European OTC company called PGT Healthcare, gain EU approval

Procter & Gamble and Teva Pharmaceutical on Monday gained European Union approval for a joint venture on the sale of nonprescription medicines to be called PGT Healthcare, according to published reports.

December 23, 2011
12 for 2012

Rather than take off for Christmas, the editors of Drug Store News took a look at the year ahead and the stories, issues and trends that will make headlines in retail pharmacy in 2012.

August 24, 2011
Counterfeit threat intensifies


A worldwide flood of counterfeit and unsafe medications is seeping into the United States and other developed countries via the Internet and porous borders, threatening public health and the security of the pharmaceutical supply chain.

June 6, 2011
FDA issues statement on E. coli outbreak in Europe

The Food and Drug Administration on Friday addressed the current outbreak of E. coli O104 in Europe.

May 17, 2011
Study: Pirfenidone may improve lung function among IPF patients

An investigational drug made by InterMune improved breathing in patients with a rare and fatal lung disease, according to results of a late-stage clinical trial published online in The Lancet last week.

March 29, 2011
Datamonitor: Global biosimilars market to reach nearly $4 billion by 2015

Any manufacturer that has the necessary resources and still is hesitating about whether to tap into biosimilars might want to go ahead and do it, if projections by British market analysis firm Datamonitor come true.

July 11, 2010
Ranir acquires Synpart biz from HemCon Medical Technologies

Ranir, an oral care consumer products company, has acquired Synpart Limited and Synpart AG from...

© 2013 Drug Store News. All Rights Reserved.